What is Beam Therapeutics's PP&E (net)?

Beam Therapeutics (BEAM) reported PP&E (net) of $101.25M in Q1 2026.

How has Beam Therapeutics's PP&E (net) changed year-over-year?

Beam Therapeutics's PP&E (net) decreased by 7.6% year-over-year, from $109.57M to $101.25M.

What is the long-term trend for Beam Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Beam Therapeutics's PP&E (net) has grown at a 22.1% compound annual growth rate (CAGR), from $38.51M to $104.5M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Beam Therapeutics BEAM PP&E (Net)

PP&E (Net) at other companies

Arrowhead ResearchARWR

$374.82M-2.6%

CRISPR TherapeuticsCRSP

$112.18M-13.3%

Cogent Biosciences, Inc.COGT

$5.3M-17.9%

PTC TherapeuticsPTCT

$52.74M-11.3%

BridgeBio PharmaBBIO

$4.94M-26.2%

Protagonist TherapeuticsPTGX

$3.78M+7.0%

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's PP&E (net)?: Beam Therapeutics (BEAM) reported PP&E (net) of $101.25M in Q1 2026.
How has Beam Therapeutics's PP&E (net) changed year-over-year?: Beam Therapeutics's PP&E (net) decreased by 7.6% year-over-year, from $109.57M to $101.25M.
What is the long-term trend for Beam Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Beam Therapeutics's PP&E (net) has grown at a 22.1% compound annual growth rate (CAGR), from $38.51M to $104.5M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.